Join the COVID-19 group to help and get support from people like you.
COVID-19 News (Page 8)
Related terms: 2019-nCoV, 2019 Novel Coronavirus, Coronavirus, SARS-CoV-2 Infection, Novel Coronavirus Pneumonia
Most Americans Believe Pandemic Policies Were Good Idea: Poll
TUESDAY, June 18, 2024 – Despite all the grumbling at the time, most Americans now look back upon pandemic-era policies as a good idea, a new poll shows. A majority of Americans see four key...
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
FRIDAY, June 14, 2024 – COVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot of the JN.1 variant that spread widely last winter, the U.S. Food and Drug...
Residual Risk Seen for Death, Postacute Sequelae in Third Year After COVID-19 Hospitalization
THURSDAY, June 13, 2024 – For individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the risks for death and postacute sequelae of COVID-19 (PASC) reduce over three...
Expert Panel Develops New Definition of Long COVID
TUESDAY, June 11, 2024 – A new proposed definition for Long COVID could help patients get the help they need, a new report from the National Academies of Sciences, Engineering and Medicine says....
Systemic Side Effects of COVID-19 Vaccine Tied to Greater nAB Response
TUESDAY, June 11, 2024 – Short-term systemic side effects of the severe acute respiratory coronavirus 2 (SARS-CoV-2) mRNA vaccine are associated with greater long-lasting neutralizing antibody (nAB)...
Moderna Announces Good Results From Trial of Combo COVID/Flu Vaccine
MONDAY, June 10, 2024 – An experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is showing positive results among older adults in trials, maker Moderna announced...
Nirmatrelvir-Ritonavir No Aid for Long COVID Symptoms
MONDAY, June 10, 2024 – A 15-day course of nirmatrelvir-ritonavir (NMV/r) is safe but does not demonstrate a significant benefit for improving postacute sequelae of SARS-CoV-2 infection (PASC)...
Extended Course of Paxlovid Adds No Benefit for Those With Long COVID
FRIDAY, June 7, 2024 – An extended course of the antiviral drug Paxlovid won’t ease a person’s Long COVID symptoms, a new study finds. People who took Paxlovid for 15 days – three times as long as i...
Long COVID's Toll Outlined in New Report
THURSDAY, June 6, 2024 – Long COVID continues to plague millions of Americans as the health costs of the pandemic linger four years later, a new report warns. In a hefty document released Wednesday,...
Long COVID's Toll Outlined in New Report
THURSDAY, June 6, 2024 – Long COVID continues to plague millions of Americans as the health costs of the pandemic linger four years later, a new report warns. In a hefty document released Wednesday,...
Long COVID's Toll Outlined in New Report
THURSDAY, June 6, 2024 – Long COVID continues to plague millions of Americans as the health costs of the pandemic linger four years later, a new report warns. In a hefty document released Wednesday,...
Long COVID's Toll Outlined in New Report
THURSDAY, June 6, 2024 – Long COVID continues to plague millions of Americans as the health costs of the pandemic linger four years later, a new report warns. In a hefty document released Wednesday,...
Long COVID's Toll Outlined in New Report
THURSDAY, June 6, 2024 – Long COVID continues to plague millions of Americans as the health costs of the pandemic linger four years later, a new report warns. In a hefty document released Wednesday,...
Long COVID's Toll Outlined in New Report
THURSDAY, June 6, 2024 – Long COVID continues to plague millions of Americans as the health costs of the pandemic linger four years later, a new report warns. In a hefty document released Wednesday,...
FDA Panel OKs New COVID Vaccine for Fall
THURSDAY, June 6, 2024 – A U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for COVID vaccines ahead of a fall campaign that will encourage Americans to...